Gilead Sciences (GILD) Other Working Capital Changes (2009 - 2026)

Gilead Sciences has reported Other Working Capital Changes for 18 years, with the latest figure at -$5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 58.33% year-over-year to -$5.0 million; the trailing twelve-month figure through Mar 2026 stood at $318.0 million (up 51.43% YoY), and the FY2025 full-year result was $311.0 million, up 20.08% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$5.0 million, down from $36.0 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $368.0 million in Q3 2025, with the low at -$81.0 million in Q2 2025.
• Historically, Other Working Capital Changes has averaged $38.8 million across 5 years, with a median of $27.0 million in 2022.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 1240.0% — and 2025, when it tumbled 526.32%.
• Gilead Sciences' Other Working Capital Changes stood at $65.0 million in 2022, then sank by 50.77% to $32.0 million in 2023, then jumped by 356.25% to $146.0 million in 2024, then tumbled by 75.34% to $36.0 million in 2025, then slumped by 113.89% to -$5.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$5.0 million (Q1 2026), $36.0 million (Q4 2025), and $368.0 million (Q3 2025), per Business Quant data.